The S&P/ASX 200 Index (ASX: XJO) is having a better session on Monday. In afternoon trade, the benchmark index is up 0.7% to 7,629.9 points.
Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:
Boss Energy Ltd (ASX: BOE)
The Boss Energy share price is up 8% to $4.74. This follows the release of the uranium producer's quarterly update this morning. That update revealed that the company's ramp-up to a steady-state production rate of 2.45Mlb of U3O8 per annum is now underway at the Honeymoon project following its successful commissioning. This saw the company produce its first drum of uranium after the quarter's end. Another positive is that the Honeymoon project is exceeding feasibility study forecasts. Management notes that this is being underpinned by the new processing technology adopted by Boss, which is central to the project's operating and financial success.
Pacific Smiles Group Ltd (ASX: PSQ)
The Pacific Smiles share price is up 16.5% to $1.90. Investors have been buying the dental company's shares after it received and accepted a new takeover offer. Pacific Smiles has entered into a scheme implementation deed with NDC HoldCo. It operates the National Dental Care centres and is a portfolio company managed by Crescent Capital Partners Management. A cash offer of $1.90 per share has been accepted. This is higher than a recent $1.75 per share from Genesis Capital. However, with its shares now trading in line with the NDC offer, it seems that some investors may be expecting an improved offer from Genesis Capital.
Perpetual Ltd (ASX: PPT)
The Perpetual share price is up 3% to $23.96. This morning, this fund manager responded to media speculation relating to a potential transaction. Perpetual confirmed that it has entered into exclusive talks with Kohlberg Kravis Roberts & Co (KKR) in relation to the potential acquisition of its Corporate Trust and Wealth Management businesses. However, it warned that there is no certainty of reaching a binding agreement or that any transaction would proceed. Perpetual intends to continue to keep the market informed in line with its continuous disclosure obligations.
ResMed Inc. (ASX: RMD)
The ResMed share price is up a further 3.5% to $32.57. Investors have been buying this sleep disorder treatment company's shares again on Monday following a very strong gain on Friday night for its NYSE listed shares. They rose 18% in response to the release of its third-quarter update. ResMed reported a 7% increase in revenue to US$1.2 billion, a 25% jump in income from operations to US$374.6 million, and a 29% lift in diluted earnings per share to US$2.04 per share.
